Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Tredaptive on Lipoproteins and Oxidative Stress
NCT01054508Phase 4Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Jun 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of laropiprant in hypercholesterolemia, sponsored by Manchester University NHS Foundation Trust. Started Jun 2010; status: completed.
02
Drugs
laropiprant
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT01054508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01054508.